Is AI the Prescription for Better Health Care?
For advisors fielding client questions about AI themes, it offers a concise framing of near-term versus longer-dated opportunities and risks in health care from Morgan Stanley’s Global Investment Office.
Summary
By the wealth tech & ai deskThis Morgan Stanley audiocast features Ellen Zentner, Chief Economic Strategist and Global Head of Thematic and Macro Investing for Morgan Stanley Wealth Management, discussing AI in health care. She explains why AI’s clearest near-term opportunity is improving care delivery, while AI-driven drug discovery remains a longer path with higher clinical and financial risk.
- AI’s clearest near-term opportunity in health care is improving care delivery.
- AI-driven drug discovery remains a longer path.
- AI-driven drug discovery carries higher clinical and financial risk.
Similar items
Same topic How Advisors and AI Agents Divide Up the Work | Parker Ence, Jump | WTWealthTech Today |
| Jump’s CEO Shares How Advisors and AI Agents Divide Up the Work | WTWealthTech Today |
 The Analyst in the Loop: How AI Is Expanding Manager Research | BTBeyond the Stars (Morningstar) |
 The Rise of the “Cyborg Advisor”: Using Technology to Scale Growth | WCWealthManagement.com |
 AI Tools for the Investment Firm – Ben Harrison (EP.522) | CACapital Allocators with Ted Seides |
Get the weekly 3 to watch
Free, in the Morning BriefEvery week the Morning Brief picks three videos and podcasts worth your time, with why each one matters.
Free. Every morning. Unsubscribe from any edition in one click.
Videos and podcasts are embedded from their publishers. Selections and summaries are editorial and are not investment advice.